Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives

This publication has 18 references indexed in Scilit:

• Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Replication by Specific Targeting of the Final Step of Virion Maturation
  Journal of Virology, 2004
• PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing
  Proceedings of the National Academy of Sciences, 2003
• Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective
  Antiviral Research, 2002
• Role of Human Immunodeficiency Virus (HIV) Type 1 Envelope in the Anti-HIV Activity of the Betulinic Acid Derivative IC9564
  Antimicrobial Agents and Chemotherapy, 2001
• Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
  New England Journal of Medicine, 1999
• Anti-AIDS Agents. 34. Synthesis and Structure−Activity Relationships of Betulin Derivatives as Anti-HIV Agents
  Journal of Medicinal Chemistry, 1998
• Anti-AIDS agents—XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives
  Bioorganic & Medicinal Chemistry, 1997
• Betulinic Acid Derivatives: A New Class of Human Immunodeficiency Virus Type 1 Specific Inhibitors with a New Mode of Action
  Journal of Medicinal Chemistry, 1996
• Betulinic Acid Derivatives: A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry
  Journal of Medicinal Chemistry, 1996
• Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.
  Proceedings of the National Academy of Sciences, 1994